<DOC>
	<DOCNO>NCT00371592</DOCNO>
	<brief_summary>The purpose study determine whether acyclovir effective suppress HIV viral load woman infect HIV-1 herpes simplex virus type 2 ( HSV-2 ) start HIV treatment first time .</brief_summary>
	<brief_title>Effectiveness Acyclovir Suppressing HIV Viral Load Women Coinfected With HIV Herpes Simplex Virus Type 2 ( HSV-2 )</brief_title>
	<detailed_description>Women coinfected HIV HSV-2 experience genital herpes outbreaks woman infect HSV-2 . Frequent recurrent herpes outbreaks woman infect HIV lead increase HIV plasma viral load cervical shed HIV . Some preliminary clinical study show acyclovir treatment management HSV-2 infection help lower HIV viral load patient coinfected HIV HSV-2 . Supplementing highly active antiretroviral therapy ( HAART ) HSV-2 treatment patient coinfected HIV HSV-2 may help strengthen effect HAART effectively lower plasma genital HIV viral load . This study determine whether HSV-2 treatment acyclovir effective control HIV plasma viral load cervical shed HIV woman start HAART per Peruvian guideline . This study last 24 week . Participants randomly assign one two group . Group 1 participant receive twice-daily 800 mg acyclovir 24 week . Group 2 participant receive twice-daily placebo 24 week . Both group receive HAART Peruvian Ministry Health . There 15 visit study . Medical history ; physical exam ; blood collection ; family planning counseling ; cervical , vaginal , vulvar swab collection begin prior study entry occur study visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>HIV1 infect HSV2 infect Initiating HAART per Peruvian guideline first time study entry CD4 count le 200 cells/mm3 OR CD4 count le 350 cells/mm3 AND viral load great 55,000 copies/ml within 30 day prior study entry Does intend move outside great metropolitan Lima , Peru area duration study Willing follow study requirement Willing provide write informed consent Prior HAART History adverse reaction acyclovir , famciclovir , valacyclovir Unwilling take acyclovir , famciclovir , valacyclovir History seizures Renal insufficiency , define serum creatinine great 2 mg/dl creatinine clearance le 50 ml/min Treatment serious medical condition 14 day prior study entry . Patients chronic , acute , recurrent opportunistic infection ( OIs ) complete therapy clinically stable therapy least 14 day prior study entry exclude . Clinically unstable untreated OIs tumor within 14 day prior study entry . More information criterion find protocol . Clinically unstable untreated bacterial sexually transmit disease ( STDs ) within 14 day prior study entry . More information criterion find protocol . Radiation therapy systemic chemotherapy within 45 day prior study entry . Participants underwent systemic chemotherapy treatment Kaposi 's sarcoma ( KS ) complete prior study entry exclude . Any immunomodulator , HIV vaccine , investigational therapy within 30 day prior study entry . Patients receive taper course corticosteroid acute therapy Pneumocystis carinii pneumonia ( PCP ) receive inhale nasal fluticasone exclude . Current drug alcohol use , investigator 's opinion , may interfere study Vomiting inability swallow medication Involuntarily incarcerate correctional facility , prison , jail detain treatment either psychiatric infectious disease Grade 2 3 highgrade cervical dysplasia cervical neoplasia within 6 month prior study entry Any condition , investigator 's opinion , may interfere study Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Treatment Naive</keyword>
</DOC>